ArticlePloS one2012

Modulation of the activity of Sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cancer.

Anastasia Malek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.